• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内保护装置在动脉开口处的隐静脉移植物病变中的作用。

Role of embolic protection devices in ostial saphenous vein graft lesions.

机构信息

VA North Texas Healthcare System and University of Texas Southwestern Medical Center, Dallas, Texas, USA.

出版信息

Catheter Cardiovasc Interv. 2012 Dec 1;80(7):1120-6. doi: 10.1002/ccd.23471. Epub 2012 Mar 15.

DOI:10.1002/ccd.23471
PMID:22422709
Abstract

BACKGROUND

Although embolic protection devices (EPDs) have been shown to be beneficial in saphenous vein graft (SVG) lesions, their role in the subgroup of ostial SVG lesions has received limited study.

METHODS

The coronary angiograms and procedural outcomes of 109 patients undergoing stenting of 113 ostial SVG lesions were retrospectively reviewed to determine the frequency of EPD use and the periprocedural outcomes.

RESULTS

Ninety-eight (87%) of the 113 lesions were suitable for EPD use, that was used in 70 lesions (71%). A Filterwire (Boston Scientific) or a SPIDER (ev3) filter were used in 54 (77%) and 16 (23%) of lesions, respectively. Difficulty retrieving the filter post stenting was encountered in eight lesions (11%) and led to stent thrombosis causing cardiac arrest in one patient (1%). Angiographic success was achieved in 111 (98%) of 113 lesions.

CONCLUSIONS

EPDs can be utilized in the majority of ostial SVG lesions, but in 11% of cases filter retrieval can be challenging and may rarely (in approximately 1%) lead to a significant complication.

摘要

背景

虽然栓塞保护装置 (EPD) 已被证明对隐静脉移植物 (SVG) 病变有益,但它们在 SVG 开口病变亚组中的作用研究有限。

方法

回顾性分析了 109 例接受 113 例 SVG 开口病变支架置入术的患者的冠状动脉造影和手术结果,以确定 EPD 使用的频率和围手术期结果。

结果

113 个病变中有 98 个(87%)适合使用 EPD,其中 70 个病变(71%)使用了 EPD。54 个病变(77%)和 16 个病变(23%)分别使用了 Filterwire(波士顿科学公司)或 SPIDER(ev3)过滤器。在 8 个病变(11%)中,在支架置入后取出过滤器遇到困难,导致支架血栓形成并导致 1 例患者心脏骤停(1%)。113 个病变中有 111 个(98%)达到了血管造影成功。

结论

EPD 可用于大多数 SVG 开口病变,但在 11%的病例中,过滤器取出可能具有挑战性,并且在极少数情况下(约 1%)可能导致严重并发症。

相似文献

1
Role of embolic protection devices in ostial saphenous vein graft lesions.血管内保护装置在动脉开口处的隐静脉移植物病变中的作用。
Catheter Cardiovasc Interv. 2012 Dec 1;80(7):1120-6. doi: 10.1002/ccd.23471. Epub 2012 Mar 15.
2
Contemporary use of embolic protection devices in saphenous vein graft interventions: Insights from the stenting of saphenous vein grafts trial.当代在隐静脉移植物介入治疗中使用栓塞保护装置:来自隐静脉支架置入试验的见解。
Catheter Cardiovasc Interv. 2010 Aug 1;76(2):263-9. doi: 10.1002/ccd.22438.
3
Embolic protection device use and its association with procedural safety and long-term outcomes following saphenous vein graft intervention: An analysis from the British Columbia Cardiac registry.隐静脉移植血管介入术后栓子保护装置的使用及其与手术安全性和长期预后的关联:来自不列颠哥伦比亚心脏注册研究的分析
Catheter Cardiovasc Interv. 2016 Jul;88(1):73-83. doi: 10.1002/ccd.26237. Epub 2015 Oct 20.
4
In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.药物洗脱支架与金属裸支架在静脉桥血管介入治疗中的院内和 1 年预后:来自 EVENT 注册研究的报告。
Catheter Cardiovasc Interv. 2012 Dec 1;80(7):1127-36. doi: 10.1002/ccd.24352. Epub 2012 May 4.
5
Outcomes of Saphenous Vein Graft Intervention With and Without Embolic Protection Device: A Comprehensive Review and Meta-Analysis.有或无栓塞保护装置的隐静脉移植干预的结果:全面综述和荟萃分析。
Circ Cardiovasc Interv. 2017 Dec;10(12). doi: 10.1161/CIRCINTERVENTIONS.117.005538.
6
Outcomes Following Percutaneous Coronary Intervention in Saphenous Vein Grafts With and Without Embolic Protection Devices.经皮冠状动脉介入治疗中应用和不应用血栓保护装置的隐静脉桥的结果。
JACC Cardiovasc Interv. 2019 Nov 25;12(22):2286-2295. doi: 10.1016/j.jcin.2019.08.037.
7
Contemporary Use of Embolic Protection Devices During Saphenous Vein Graft Intervention.当代应用于隐静脉移植介入术的栓塞保护装置。
Circ Cardiovasc Interv. 2019 May;12(5):e007636. doi: 10.1161/CIRCINTERVENTIONS.118.007636.
8
A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial.一种用于隐静脉桥病变经皮介入治疗的新型基于滤器的远端栓塞保护装置:紫水晶随机对照试验结果
JACC Cardiovasc Interv. 2008 Jun;1(3):248-57. doi: 10.1016/j.jcin.2008.03.009.
9
Correlates of adverse events during saphenous vein graft intervention with distal embolic protection: a PRIDE substudy.大隐静脉移植介入术中使用远端栓塞保护装置时不良事件的相关因素:一项PRIDE子研究
JACC Cardiovasc Interv. 2008 Apr;1(2):186-91. doi: 10.1016/j.jcin.2008.01.002.
10
Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.在 SOS(静脉桥血管支架置入术)试验的长期随访中,紫杉醇洗脱支架与裸金属支架置入相比,在静脉桥病变中持续获益。
JACC Cardiovasc Interv. 2011 Feb;4(2):176-82. doi: 10.1016/j.jcin.2010.10.003.

引用本文的文献

1
Outcomes Following Percutaneous Coronary Intervention in Saphenous Vein Grafts With and Without Embolic Protection Devices: A Systematic Review and Meta-Analysis.有无栓塞保护装置的隐静脉移植物经皮冠状动脉介入治疗后的结果:一项系统评价和荟萃分析。
Front Cardiovasc Med. 2022 Jan 21;8:726579. doi: 10.3389/fcvm.2021.726579. eCollection 2021.
2
Saphenous vein graft interventions.大隐静脉移植干预措施。
Curr Treat Options Cardiovasc Med. 2014 May;16(5):301. doi: 10.1007/s11936-014-0301-x.